Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRADD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LASP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C20orf141 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TEX40 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | ZNF852 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | GPR155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GYG1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |